As well, our previous study suggested that compared with chemotherapy and DLI with unstimulated lymphocytes, chemotherapy and G-CSF mobilized peripherial blood cells infusion tended to be associated with a higher complete remission rate (7/9 vs. 3/5) in patients with relapsed acute leukemia after allo-HSCT [26]. The gene discussed is CSF3; the disease is acute leukemia.